e-learning
resources
Munich 2014
Tuesday, 09.09.2014
Acute lung injury: hitting the barriers
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Human mesenchymal stem cells (MSC) modulate alveolar macrophage polarization
in vivo
and
in vitro.
A. Krasnodembskaya, T. Morrison, C. O'Kane, D. McAuley, M. Matthay (San Francisco, United States Of America; Belfast, United Kingdom)
Source:
International Congress 2014 – Acute lung injury: hitting the barriers
Session:
Acute lung injury: hitting the barriers
Session type:
Oral Presentation
Number:
3427
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Krasnodembskaya, T. Morrison, C. O'Kane, D. McAuley, M. Matthay (San Francisco, United States Of America; Belfast, United Kingdom). Human mesenchymal stem cells (MSC) modulate alveolar macrophage polarization
in vivo
and
in vitro.
. Eur Respir J 2014; 44: Suppl. 58, 3427
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Related content which might interest you:
Src regulates ventilation-induced epithelial-mesenchymal transition and epithelial apoptosis
Source: International Congress 2014 – Acute lung injury: hitting the barriers
Year: 2014
Microvesicles derived from alveolar macrophages mediate epithelial activation via a TNF dependant mechanism
Source: International Congress 2015 – Novel insights into the pathobiology of acute lung injury
Year: 2015
Mesenchymal stem cell-conditioned medium induces neutrophils apoptosis via inhibition of NF-kB pathway and increases endogenous pulmonary stem cells in endotoxin-induced acute lung injury
Source: International Congress 2015 – The multiple facets of stem and progenitor cells in lung health and disease
Year: 2015
Heparin effect in alveolar cells and macrophages in an acute lung injury model
Source: International Congress 2015 – Novel insights into the pathobiology of acute lung injury
Year: 2015
Cell therapy for the treatment of acute lung injury: Alveolar type II cells or mesenchymal stem cells?
Source: International Congress 2016 – Novel insights into alveolar and bronchial epithelial cell injury and repair
Year: 2016
Heparin effect in pulmonary cell populations in an in-vitro model of acute lung injury
Source: International Congress 2016 – Studies in airway cell biology
Year: 2016
Lung inflammation was attenuated by sakuranetin treatment in a model of acute lung injury
Source: International Congress 2014 – Experimental models in acute lung injury
Year: 2014
LATE-BREAKING ABSTRACT: Trasplantation of alveolar type II cells in experimental Acute Lung Injury
Source: International Congress 2014 – Lung cell biology in injury and repair
Year: 2014
Long-term effects of nebulized LPS in a mouse model of acute lung injury (ALI)
Source: International Congress 2014 – ILDs 6
Year: 2014
Orotracheal instillation of gastric juice: Species variations in acute lung injury relate to differences in matrix metalloproteinase activity
Source: International Congress 2014 – Experimental models in acute lung injury
Year: 2014
Induced pluripotent stem cells conditioned media (iPS-cm) modulates macrophage phenotype in the fibrotic lung
Source: International Congress 2014 – Lung cell biology in injury and repair
Year: 2014
Characterization of ceramide generation kinetics in a lung injury model induced by lipopolysaccharide
Source: International Congress 2015 – Respiratory muscles and airways function: from physiology to clinical implications
Year: 2015
Obesity modulates the alveolar macrophage response
Source: International Congress 2015 – Novel insights into the pathobiology of acute lung injury
Year: 2015
ATP selectively packages TNF within microvesicles released from alveolar macrophages
Source: International Congress 2016 – Novel insights into alveolar and bronchial epithelial cell injury and repair
Year: 2016
TNF and IP-10 drive inflammation into hyperinflammation in the murine lung
Source: Annual Congress 2013 –The role of hormones and cytokines in lung injury
Year: 2013
Essential oils reduced lung inflammation in a model of acute lung injury
Source: International Congress 2014 – Experimental models in acute lung injury
Year: 2014
The role of SIRT1 in LPS-induced lung endothelial barrier dysfunction and lung injury in vivo
Source: International Congress 2016 – Molecular targets in pulmonary disease
Year: 2016
Disease-derived extracellular matrix scaffolds instruct the transdifferentiation and migration of lung fibroblasts
Source: International Congress 2014 – New and old players in fibrotic lung disease
Year: 2014
Effects of extracellular vesicles from mesenchymal stromal cells in experimental silicosis
Source: International Congress 2014 – Pulmonary fibrosis: receptors, signalling pathways and mesenchymal cells
Year: 2014
Lung epithelial pten controls epithelial barrier integrity in vitro and in vivo
Source: Annual Congress 2013 –Acute lung injury: novel clinical and experimental insights
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept